PHASE 3 RANDOMIZED STUDY OF DARATUMUMAB (DARA) MONOTHERAPY VERSUS ACTIVE MONITORING IN PATIENTS (PTS) WITH HIGH-RISK SMOLDERING MULTIPLE MYELOMA (SMM): PRIMARY RESULTS OF THE AQUILA STUDY
Por:
Dimopoulos, MA, Voorhees, PM, Schjesvold, F, Cohen, YC, Hungria, V, Sandhu, I, Lindsay, J, Baker, RI, Suzuki, K, Kosugi, H, Levin, M, Beksac, M, Stockerl-Goldstein, K, Oriol, A, Mikala, G, Garate, G, Theunissen, K, Spicka, I, Mylin, AK, Bringhen, S, Uttervall, K, Pula, B, Medvedova, E, Cowan, AJ, Moreau, P, Mateos, MV, Goldschmidt, H, Ahmadi, T, Sha, L, Rousseau, E, Li, L, Dennis, RM, Carson, R and Rajkumar, SV
Publicada:
1 abr 2025
Resumen:
Filiaciones:
Dimopoulos, MA:
Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Athens, Greece
Voorhees, PM:
Wake Forest Univ, Sch Med, Atrium Hlth, Levine Canc Inst, Winston Salem, NC USA
Schjesvold, F:
Oslo Univ Hosp, Dept Hematol, Oslo Myeloma Ctr, Oslo, Norway
Cohen, YC:
Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel
Tel Aviv Univ, Tel Aviv, Israel
Hungria, V:
Clin Med Sao Germano, Sao Paulo, Brazil
Sandhu, I:
Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
Lindsay, J:
Kent & Canterbury Hosp, Canterbury, Kent, England
Baker, RI:
Murdoch Univ, Perth Blood Inst, Murdoch, WA, Australia
Suzuki, K:
Japanese Red Cross Med Ctr, Tokyo, Japan
Kosugi, H:
Ogaki Municipal Hosp, Ogaki, Japan
Levin, M:
Albert Schwitzer Hosp, Dordrecht, Netherlands
Beksac, M:
Ankara Univ, Ankara, Turkiye
Stockerl-Goldstein, K:
Washington Univ, Sch Med, St Louis, MO USA
:
Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain
Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain
Mikala, G:
South Pest Cent Hosp, Natl Inst Hematol & Infect Dis, Budapest, Hungary
Garate, G:
Hosp Aleman, Buenos Aires, DF, Argentina
Theunissen, K:
Jessa Hosp, Hasselt, Belgium
Spicka, I:
Charles Univ Prague, Prague, Czech Republic
Gen Hosp, Prague, Czech Republic
Mylin, AK:
Univ Copenhagen, Rigshosp, Copenhagen, Denmark
Bringhen, S:
AOU Citta Salute & Sci Torino, SSD Clin Trials Oncol Ematol Mieloma Multiplo, Turin, Italy
Uttervall, K:
Karolinska Univ Hosp, Med Unit Hematol, Stockholm, Sweden
Pula, B:
Inst Hematol & Transfus Med, Warsaw, Poland
Medvedova, E:
Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA
Cowan, AJ:
Univ Washington, Seattle, WA USA
Fred Hutchinson Canc Ctr, Seattle, WA USA
Moreau, P:
Univ Hosp Hotel Dieu, Paris, France
Mateos, MV:
Univ Hosp Salamanca, IBSAL, Canc Res Ctr, IBMCC,USAL,CSIC, Salamanca, Spain
Goldschmidt, H:
Univ Hosp Heidelberg, GMMG Study Grp, Internal Med 5, Heidelberg, Germany
Ahmadi, T:
Genmab US Inc, Cambridge, MA USA
Sha, L:
Janssen Res & Dev, Beijing, Peoples R China
Rousseau, E:
Janssen Res & Dev, Beerse, Belgium
Li, L:
Janssen Res & Dev, Beijing, Peoples R China
Dennis, RM:
Janssen Res & Dev, Raritan, NJ USA
Carson, R:
Janssen Res & Dev, Raritan, NJ USA
Rajkumar, SV:
Mayo Clin, Rochester, MN USA
|